This idea is consistent, for example, with the observation that a dominant-negative mutant version of the IGF1 receptor, but not the concurrent elimination of both the insulin and IGF1 receptors, triggers hyperglycemia and hyperinsulinemia when expressed in the skeletal muscle9. This evidence concerns the gene INS and Hyperglycemia.